Harbour Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.78M | Sell |
14,438
-16
| -0.1% | -$1.87K | 0.32% | 74 |
|
|
2026
Q1 | $1.63M | Buy |
14,454
+1,021
| +8% | +$118K | 0.31% | 79 |
|
|
2025
Q4 | $1.43M | Hold |
13,433
| – | – | 0.29% | 79 |
|
|
2025
Q3 | $1.18M | Sell |
13,433
-278
| -2% | -$22.9K | 0.24% | 95 |
|
|
2025
Q2 | $1.13M | Sell |
13,711
-459
| -3% | -$36.5K | 0.24% | 97 |
|
|
2025
Q1 | $1.22M | Sell |
14,170
-18,839
| -57% | -$1.76M | 0.3% | 83 |
|
|
2024
Q4 | $3.27M | Sell |
33,009
-3,225
| -9% | -$332K | 0.73% | 38 |
|
|
2024
Q3 | $4M | Sell |
36,234
-30
| -0.1% | -$3.56K | 0.92% | 30 |
|
|
2024
Q2 | $4.64M | Buy |
36,264
+60
| +0.2% | +$7.73K | 1.1% | 23 |
|
|
2024
Q1 | $4.72M | Buy |
36,204
+69
| +0.2% | +$8.51K | 1.17% | 23 |
|
|
2023
Q4 | $4.15M | Buy |
36,135
+223
| +0.6% | +$23.1K | 1.14% | 24 |
|
|
2023
Q3 | $3.7M | Buy |
35,912
+840
| +2% | +$90.5K | 1.11% | 24 |
|
|
2023
Q2 | $4.01M | Sell |
35,072
-827
| -2% | -$93.9K | 1.18% | 21 |
|
|
2023
Q1 | $3.82M | Buy |
35,899
+1,894
| +6% | +$204K | 1.16% | 24 |
|
|
2022
Q4 | $3.78M | Sell |
34,005
-504
| -1% | -$51.5K | 1.27% | 22 |
|
|
2022
Q3 | $3.12M | Sell |
34,509
-165
| -0.5% | -$14.7K | 1.08% | 26 |
|
|
2022
Q2 | $3.16M | Buy |
34,674
+105
| +0.3% | +$9.31K | 1.03% | 28 |
|
|
2022
Q1 | $2.84M | Buy |
34,569
+310
| +0.9% | +$24.4K | 0.78% | 43 |
|
|
2021
Q4 | $2.63M | Buy |
34,259
+231
| +0.7% | +$18.4K | 0.65% | 51 |
|
|
2021
Q3 | $2.56M | Buy |
34,028
+750
| +2% | +$57K | 0.67% | 49 |
|
|
2021
Q2 | $2.59M | Sell |
33,278
-997
| -3% | -$74.2K | 0.7% | 45 |
|
|
2021
Q1 | $2.52M | Buy |
34,275
+446
| +1% | +$32.9K | 0.74% | 42 |
|
|
2020
Q4 | $3K | Buy |
33,829
+708
| +2% | +$54.1K | 1.49% | 28 |
|
|
2020
Q3 | $2.62M | Buy |
33,121
+512
| +2% | +$40.1K | 0.96% | 32 |
|
|
2020
Q2 | $2.41M | Buy |
32,609
+1,965
| +6% | +$148K | 0.98% | 30 |
|
|
2020
Q1 | $2.25M | Buy |
30,644
+1,405
| +5% | +$110K | 1.14% | 25 |
|
|
2019
Q4 | $2.54M | Buy |
29,239
+440
| +2% | +$36.1K | 0.97% | 28 |
|
|
2019
Q3 | $2.31M | Buy |
28,799
+2,578
| +10% | +$207K | 0.98% | 29 |
|
|
2019
Q2 | $2.1M | Buy |
26,221
+383
| +1% | +$29.3K | 0.9% | 32 |
|
|
2019
Q1 | $2.05M | Buy |
25,838
+303
| +1% | +$22.7K | 0.91% | 29 |
|
|
2018
Q4 | $1.86M | Buy |
25,535
+226
| +0.9% | +$16K | 0.92% | 29 |
|
|
2018
Q3 | $1.71M | Buy |
25,309
+647
| +3% | +$41.2K | 0.69% | 41 |
|
|
2018
Q2 | $1.42M | Buy |
24,662
+3,616
| +17% | +$204K | 0.61% | 52 |
|
|
2018
Q1 | $1.09M | Buy |
21,046
+11,157
| +113% | +$603K | 0.47% | 80 |
|
|
2017
Q4 | $531K | Sell |
9,889
-2,681
| -21% | -$149K | 0.22% | 133 |
|
|
2017
Q3 | $768K | Buy |
+12,570
| New | +$762K | 0.33% | 104 |
|
|
2017
Q2 | – | Sell |
-2,090
| Closed | -$127K | – | 463 |
|
|
2017
Q1 | $127K | Buy |
+2,090
| New | +$127K | 0.06% | 259 |
|
|
2016
Q4 | – | Sell |
-2,247
| Closed | -$134K | – | 229 |
|
|
2016
Q3 | $134K | Buy |
+2,247
| New | +$131K | 0.08% | 221 |
|
Other funds holding MRK
LMFP
ATO
QP
Harbour Capital Advisors's MRK Position: Q2 2026 in Review
Harbour Capital Advisors reduced its Merck (MRK) stake by 0.11% in Q2 2026, selling an estimated $1.87K and leaving 14,438 shares worth $1.78M. The position accounts for 0.32% of the portfolio, ranked #74.
Harbour Capital Advisors first reported a position in MRK in Q3 2016 and has held it in 38 quarters since. The position peaked at $4.72M in Q1 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Harbour Capital Advisors held 14,438 shares of Merck worth $1.78M as of Q2 2026.
- Harbour Capital Advisors sold 16 Merck shares in Q2 2026, an estimated $1.87K.
- Merck made up 0.32% of Harbour Capital Advisors's portfolio in Q2 2026, its #74 holding.
- Harbour Capital Advisors first reported a position in Merck in Q3 2016 and has held it in 38 quarters since.
- Harbour Capital Advisors's Merck position peaked at $4.72M in Q1 2024.
- 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Harbour Capital Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.